Embattled German conglomerate Bayer, which reduced its workforce by 3,200 positions in the first half of the year, has reportedly announced further layoffs this week as it continues to navigate its financial and operational challenges. In a setback for Aadi, the company's plans to widen the use of its key drug were derailed by disappointing results from a phase II solid tumor trial. Meanwhile, on the regulatory front, the FDA has approved updated COVID-19 vaccines that target KP.2 strain to enhance protection this fall. Additionally, Johnson & Johnson made headlines by expanding its MedTech cardiovascular portfolio through a new acquisition, marking a significant move in its growth strategy.
Let's dive into the details.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.